Alamar Biosciences Inc (ALMR) Stock Analysis

Verdict: WATCH (do not buy)

High-sensitivity proteomics platform fuels 80%+ revenue growth, but extreme 42x P/S valuation and overbought technicals signal a near-term pullback risk.

Investment score: 58/100

Analysis as of

Is Alamar Biosciences Inc stock worth reviewing? AI model thesis

Alamar Biosciences is executing well on top-line growth and partnership expansion, but the post-earnings rally has pushed valuation to a level that demands perfection. The model suggests waiting for a technical cooling-off period.

7-factor investment score

Alamar Biosciences Inc opportunities and risks

What speaks for ALMR

What speaks against ALMR

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
ALMRn/a42.7xn/a58.0%-62.2%-1.5%
BRKRn/a2.6x43.0x46.7%-2.0%1.1%
TXGn/a12.1x252.1x70.0%-12.2%1.6%
SHC33.2x4.5x13.6x54.7%13.4%2.1%
ADPTn/a13.0xn/a75.4%-20.7%-0.6%
Peer mediann/a8.3x28.3x62.4%-7.1%1.3%

Frequently asked questions about Alamar Biosciences Inc (ALMR)

Is ALMR stock a good investment?

The cached TradeMates AI model rates Alamar Biosciences Inc as WATCH (do not buy) with an investment score of 58/100. Alamar Biosciences is executing well on top-line growth and partnership expansion, but the post-earnings rally has pushed valuation to a level that demands perfection. The model suggests waiting for a technical cooling-off period. This is algorithmic model output, not personal investment advice.

Is ALMR stock a buy?

The TradeMates model verdict for ALMR is WATCH (do not buy) with an investment score of 58/100. Treat this as a model signal to review, not a personal buy recommendation.